Table 2.
Mouse Adaptation Mutation | Adapted Strain | Adaptation Procedure | Replication in Cell Lines | Virulence in an Animal Model | References |
---|---|---|---|---|---|
VP2-K149M | MP4 | Four passages in 1-day-old ICR mice | MP4 is highly proliferative in several human cell lines | VP2-K149M and VP1-Q145E are together responsible for mouse virulence | [31,33] |
VP2-K149I | CHO-26M MP-26M |
Six passages in a hamster cell line (CHO), then f our passages in suckling mice |
NT | VP2-K149I did not contribute much, and VP1-G145E was the most critical mutation | [30] |
VP2-K149I VP2-K149M |
1095-LPS1 SK-EV006-LPS1 C7/Osaka-LPS1 75-Yamagata-LPS1 |
One passage in a human PSGL1 overexpressing mouse cell line (L-PSGL1) | Adaptation increased proliferation in L-PSGL1 | NT | [56] |
VP2-K149I VP2-K149M |
CHO-B5 CHO-C2 |
Four to eight passages in a hamster cell line (CHO) | CHO-B5, CHO-C4, and the parental strains containing VP2-K149I or VP2-K149M showed enhanced proliferation in CHO cells. All of these viruses are VP1-145Q (HS-binding) | NT | [48] |
VP2-K149I | EV71:TLLm EV71:TLLmv |
60 and 100 passages in a mouse cell line (NIH/3T3) | TLLm and TLLmv show increased efficiency for infecting various rodent cell lines, but the VP2-K149I point mutant does not show the same increase in infection in such cells. The reason for this may be that the strains used are HS-nonbinding | No increase in virulence was observed with VP2-K149I | [57,58] |
VP2-K149I | GZ-CII | VP2-149I have been isolated from a human patient | NT | GZ-CII and artificially mutated VP2-K149I viruses are highly virulent in mice | [55] |
NT: not tested.